Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Total Non-Current Liabilities (2019 - 2025)

Harmony Biosciences Holdings' Total Non-Current Liabilities history spans 7 years, with the latest figure at $149.3 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 9.51% year-over-year to $149.3 million; the TTM value through Dec 2025 reached $149.3 million, down 9.51%, while the annual FY2025 figure was $149.3 million, 9.51% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $149.3 million at Harmony Biosciences Holdings, roughly flat from $149.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $196.5 million in Q2 2021 and bottomed at $149.3 million in Q4 2025.
  • The 5-year median for Total Non-Current Liabilities is $183.0 million (2023), against an average of $179.0 million.
  • The largest annual shift saw Total Non-Current Liabilities increased 0.4% in 2022 before it decreased 11.97% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $193.2 million in 2021, then decreased by 0.52% to $192.1 million in 2022, then dropped by 5.97% to $180.7 million in 2023, then dropped by 8.7% to $165.0 million in 2024, then fell by 9.51% to $149.3 million in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Total Non-Current Liabilities are $149.3 million (Q4 2025), $149.7 million (Q3 2025), and $154.8 million (Q2 2025).